Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 24, 2012, Pages 9593-9598

  Marquitz, Aron R ^a   Mathur, Anuja ^a   Shair, Kathy H Y ^a   Raab Traub, Nancy ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Gastric carcinoma; Herpes virus; Oncogenesis

Indexed keywords

ALPHA5 INTEGRIN; CASPASE 3; CYCLIN D2; INTERFERON REGULATORY FACTOR 1; LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2; MICRORNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 3; PROTEIN MCL 1; STAT6 PROTEIN; TRANSCRIPTION FACTOR FKHRL1;

ANCHORAGE DEPENDENCE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL AGGREGATION; CELL DEATH; CELL DENSITY; CELL EXPANSION; CELL GROWTH; CELL HOMING; CELL INFILTRATION; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL MOTION; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CELL TRANSFORMATION; CHEMOTAXIS; COLONY FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; STOMACH CARCINOMA;

CELL ADHESION; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; HERPESVIRUS 4, HUMAN; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

EID: 84862189812     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1202910109     Document Type: Article

References (41)

1. Rickinson AB, Kieff E (2001) Epstein-Barr virus. Field's Virology, eds Knipe DM, Howley PM (Lippincott Williams & Wilkins, Philadelphia), 4th Ed, pp 2575-2627.
2. Raab-Traub N (2002) Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 12:431-441.
3. Rowe M, et al. (1987) Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 6: 2743-2751.
4. Lee HS, Chang MS, Yang HK, Lee BL, Kim WH (2004) Epstein-barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with epstein-barr virus-negative carcinoma. Clin Cancer Res 10:1698-1705. (Pubitemid 38435561)
5. Gilligan K, et al. (1990) Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma. J Virol 64:4948-4956. (Pubitemid 20329817)
6. Karran L, Gao Y, Smith PR, Griffin BE (1992) Expression of a family of complementarystrand transcripts in Epstein-Barr virus-infected cells. Proc Natl Acad Sci USA 89: 8058-8062.
7. Cai X, et al. (2006) Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2:e23.
8. Pfeffer S, et al. (2004) Identification of virus-encoded microRNAs. Science 304: 734-736. (Pubitemid 38560879)
9. Zhu JY, et al. (2009) Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J Virol 83:3333-3341.
10. Bartel DP (2004) MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297.
11. Edwards RH, Marquitz AR, Raab-Traub N (2008) Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. J Virol 82:9094-9106.
12. Kim N, et al. (2007) Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol 81:1033-1036.
13. Chen SJ, et al. (2010) Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS ONE 5:e12745.
14. Raab-Traub N, Dambaugh T, Kieff E (1980) DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative. Cell 22:257-267. (Pubitemid 11226447)
15. Feederle R, et al. (2011) The members of an Epstein-Barr virus microRNA cluster cooperate to transform B lymphocytes. J Virol 85:9801-9810.
16. Seto E, et al. (2010) Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. PLoS Pathog 6:e1001063.
17. Choy EY, et al. (2008) An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med 205:2551-2560.
18. Dölken L, et al. (2010) Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe 7:324-334.
19. Marquitz AR, Mathur A, Nam CS, Raab-Traub N (2011) The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim. Virology 412:392-400.
20. Wong AM, Kong KL, Tsang JW, Kwong DL, Guan XY (2012) Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Cancer 118:698-710.
21. Molesworth SJ, Lake CM, Borza CM, Turk SM, Hutt-Fletcher LM (2000) Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells. J Virol 74:6324-6332. (Pubitemid 30429797)
22. Kaye KM, Izumi KM, Kieff E (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 90: 9150-9154. (Pubitemid 23306469)
23. Wang D, Liebowitz D, Kieff E (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840.
24. Brennan P, Floettmann JE, Mehl A, Jones M, Rowe M (2001) Mechanism of action of a novel latent membrane protein-1 dominant negative. J Biol Chem 276:1195-1203. (Pubitemid 32096546)
25. Kassis J, et al. (2002) EBV-expressing AGS gastric carcinoma cell sublines present increased motility and invasiveness. Int J Cancer 99:644-651. (Pubitemid 34538742)
26. Sivachandran N, et al. (2012) Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma. J Virol 86:60-68.
27. Baek D, et al. (2008) The impact of microRNAs on protein output. Nature 455:64-71.
28. Gottwein E, et al. (2011) Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 10:515-526.
29. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. (Pubitemid 40094598)
30. Maragkakis M, et al. (2009) DIANA-microT web server: Elucidating microRNA functions through target prediction. Nucleic Acids Res 37(Web Server issue):W273-W276.
31. Wood VH, et al. (2007) Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways. Oncogene 26:4135-4147. (Pubitemid 46920177)
32. Iwakiri D, Eizuru Y, Tokunaga M, Takada K (2003) Autocrine growth of Epstein-Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA. Cancer Res 63:7062-7067. (Pubitemid 37413440)
33. Iwakiri D, et al. (2009) Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J Exp Med 206: 2091-2099.
34. Feng WH, et al. (2007) ZEB1 and c-Jun levels contribute to the establishment of highly lytic Epstein-Barr virus infection in gastric AGS cells. J Virol 81:10113-10122.
35. Mayr C, Bartel DP (2009) Widespread shortening of 3′UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138:673-684.
36. Busson P, et al. (1988) Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int J Cancer 42:599-606. (Pubitemid 18264074)
37. Mainou BA, Everly DN, Jr., Raab-Traub N (2007) Unique signaling properties of CTAR1 in LMP1-mediated transformation. J Virol 81:9680-9692. (Pubitemid 350067673)
38. Li XP, Li G, Peng Y, Kung HF, Lin MC (2004) Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cells. Biochem Biophys Res Commun 315:212-218. (Pubitemid 38175207)
39. Mei YP, et al. (2007) Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells. Cell Cycle 6:1379-1385.
40. Mainou BA, Everly DN, Jr., Raab-Traub N (2005) Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. Oncogene 24:6917-6924. (Pubitemid 41509414)
41. Thornburg NJ, Pathmanathan R, Raab-Traub N (2003) Activation of nuclear factorkappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. Cancer Res 63:8293-8301. (Pubitemid 37549481)